South Dakota Investment Council’s Vanda Pharmaceuticals VNDA Stock Holding History

South Dakota Investment Council’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,200	Closed	-$333K	–	627
2021 Q1	$333K	Hold	22,200	–	–	0.01%	575
2020 Q4	$292K	Hold	22,200	–	–	0.01%	562
2020 Q3	$214K	Hold	22,200	–	–	﹤0.01%	560
2020 Q2	$254K	Hold	22,200	–	–	0.01%	536
2020 Q1	$230K	Hold	22,200	–	–	0.01%	512
2019 Q4	$364K	Buy	22,200 +8,300	+60%	+$125K	0.01%	517
2019 Q3	$185K	Buy	13,900 +7,500	+117%	+$105K	﹤0.01%	578
2019 Q2	$90K	Hold	6,400	–	–	﹤0.01%	582
2019 Q1	$118K	Hold	6,400	–	–	﹤0.01%	576
2018 Q4	$167K	Buy	+6,400	New	+$150K	﹤0.01%	570

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

South Dakota Investment Council's VNDA Position: Q2 2021 in Review

South Dakota Investment Council sold out of Vanda Pharmaceuticals (VNDA) in Q2 2021, closing a stake of 22,200 shares — an estimated $333K sold.

South Dakota Investment Council first reported a position in VNDA in Q4 2018 and held it in 10 quarters. The position peaked at $364K in Q4 2019. 181 funds tracked by Wall St. Rank hold VNDA as of Q2 2021.

South Dakota Investment Council reported no remaining Vanda Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
South Dakota Investment Council sold 22,200 Vanda Pharmaceuticals shares in Q2 2021, an estimated $333K.
South Dakota Investment Council first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 10 quarters.
South Dakota Investment Council's Vanda Pharmaceuticals position peaked at $364K in Q4 2019.
181 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2021.

Based on South Dakota Investment Council's 13F filing for Q2 2021, filed 11 Aug 2021.